Modular Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Modular Medical (MODD).

Price Target Range — 1 Quarters

Analyst Consensus

Consensus RatingSpeculative BuyAvg. Consensus PT$150Upside to Avg. PT+8374.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 21, 2024	Benchmark	Bruce Jackson	Maintained	Speculative Buy	$150

Analyst Ratings News

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

Benchmark analyst Bruce Jackson reiterates Modular Medical (NASDAQ:MODD) with a Speculative Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

Oppenheimer analyst Steven Lichtman reiterates Modular Medical (NASDAQ:MODD) with a Outperform and maintains $3.5 price target.

Benzinga Newsdesk

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

Benchmark analyst Bruce Jackson reiterates Modular Medical (NASDAQ:MODD) with a Speculative Buy and maintains $5 price target.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

Oppenheimer analyst Steven Lichtman maintains Modular Medical (NASDAQ:MODD) with a Outperform and lowers the price target from $6 to $3.5.

Benzinga Newsdesk

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benchmark analyst Bruce Jackson maintains Modular Medical (NASDAQ:MODD) with a Speculative Buy and lowers the price target from $8 to $5.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

Upgrades

Benzinga Insights

Modular Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Modular Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

People Also Watch

People Also Watch

Modular Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Modular Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBenchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PROOppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PROBenchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PROOppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PROBenchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5

Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022

People Also Watch

People Also Watch

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Reiterates Outperform on Modular Medical, Maintains $3.5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target

PRO
Oppenheimer Maintains Outperform on Modular Medical, Lowers Price Target to $3.5

PRO
Benchmark Maintains Speculative Buy on Modular Medical, Lowers Price Target to $5